Medline Inc. (MDLN)

Medline Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	28,432	25,507	23,231	21,448
Revenue Growth (YoY)	11.47%	9.80%	8.31%	-
Cost of Revenue	20,914	18,531	17,346	16,231
Gross Profit	7,518	6,976	5,885	5,217
Selling, General & Admin	4,524	4,108	3,867	3,676
Depreciation & Amortization Expenses	704	685	662	660
Other Operating Expenses	78	37	106	20
Total Operating Expenses	5,306	4,830	4,635	4,356
Operating Income	2,212	2,146	1,250	861
Total Non-Operating Income (Expense)	-964	-900	-986	-851
Pretax Income	1,248	1,246	264	10
Provision for Income Taxes	91	46	30	35
Net Income	1,159	1,200	234	-25
Minority Interest in Earnings	-2	-	-	-
Net Income to Common	1,159	1,200	234	-25
Net Income Growth	-3.42%	412.82%	-	-
Shares Outstanding (Basic)	810	-	-	-
Shares Outstanding (Diluted)	810	-	-	-
EPS (Basic)	-0.01	-	-	-
EPS (Diluted)	-0.01	-	-	-
Shares Outstanding	812	-	-	-
Free Cash Flow	1,297	1,415	1,410	-67
Free Cash Flow Growth	-8.34%	0.36%	-	-
Free Cash Flow Per Share	1.60	-	-	-
Gross Margin	26.44%	27.35%	25.33%	24.32%
Operating Margin	7.78%	8.41%	5.38%	4.01%
Profit Margin	4.07%	4.70%	1.01%	-0.12%
FCF Margin	4.56%	5.55%	6.07%	-0.31%
EBITDA	3,223	3,123	2,201	1,794
EBITDA Margin	11.34%	12.24%	9.47%	8.36%
EBIT	2,212	2,146	1,250	861
EBIT Margin	7.78%	8.41%	5.38%	4.01%
Effective Tax Rate	7.29%	3.69%	11.36%	350.00%

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q